115 related articles for article (PubMed ID: 38279420)
1. Anti-cancer activity of microbubble conjugated with Sorafenib containing liposome and IL4R-targeting peptide in kidney cancer cells.
Lee J; Park SH
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):266-271. PubMed ID: 38279420
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel microbubble-liposome complex conjugated with peptide ligands targeting IL4R on brain tumor cells.
Park SH; Yoon YI; Moon H; Lee GH; Lee BH; Yoon TJ; Lee HJ
Oncol Rep; 2016 Jul; 36(1):131-6. PubMed ID: 27220374
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-mediated gene and drug delivery using a microbubble-liposome particle system.
Yoon YI; Kwon YS; Cho HS; Heo SH; Park KS; Park SG; Lee SH; Hwang SI; Kim YI; Jae HJ; Ahn GJ; Cho YS; Lee H; Lee HJ; Yoon TJ
Theranostics; 2014; 4(11):1133-44. PubMed ID: 25250094
[TBL] [Abstract][Full Text] [Related]
4. [Gefitinib/chloroquine-liposome-microbubble complexes as ultrasound-triggered therapeutic particles for head and neck squamous cell carcinoma in vitro].
Zhou L; Gong X; Xiong P
Shanghai Kou Qiang Yi Xue; 2020 Apr; 29(2):168-173. PubMed ID: 32626880
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma.
Ma J; Wang Y; Xi X; Tang J; Wang L; Wang L; Wang D; Liang X; Zhang B
Front Endocrinol (Lausanne); 2023; 14():1052862. PubMed ID: 36936158
[TBL] [Abstract][Full Text] [Related]
6. Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth.
Zhao G; Huang Q; Wang F; Zhang X; Hu J; Tan Y; Huang N; Wang Z; Wang Z; Cheng Y
Cancer Lett; 2018 Apr; 418():147-158. PubMed ID: 29339208
[TBL] [Abstract][Full Text] [Related]
7. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
Kang MH; Park MJ; Yoo HJ; hyuk KY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
Eur J Pharm Biopharm; 2014 Aug; 87(3):489-99. PubMed ID: 24704199
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy.
Ye H; Zhou L; Jin H; Chen Y; Cheng D; Jiang Y
Biomed Res Int; 2020; 2020():1351046. PubMed ID: 32461962
[TBL] [Abstract][Full Text] [Related]
9. STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors.
Ramasamy T; Chen X; Qin B; Johnson DE; Grandis JR; Villanueva FS
PLoS One; 2020; 15(11):e0242264. PubMed ID: 33206698
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
Bae YJ; Yoon YI; Yoon TJ; Lee HJ
Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study.
Lee S; Kim JH; Moon H; Lee HJ; Han JK
PLoS One; 2020; 15(12):e0243815. PubMed ID: 33306731
[TBL] [Abstract][Full Text] [Related]
13. Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages.
Alsaab HO; Sau S; Alzhrani RM; Cheriyan VT; Polin LA; Vaishampayan U; Rishi AK; Iyer AK
Biomaterials; 2018 Nov; 183():280-294. PubMed ID: 30179778
[TBL] [Abstract][Full Text] [Related]
14. Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation.
Zhang Z; Wu H; Zhang Y; Shen C; Zhou F
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):559-574. PubMed ID: 37490119
[TBL] [Abstract][Full Text] [Related]
15. Release of vascular agonists from liposome-microbubble conjugate by ultrasound-mediated microbubble destruction: effect on vascular function.
Franco-Urquijo CA; Navarro-Becerra JÁ; Ríos A; Escalante B
Drug Deliv Transl Res; 2022 May; 12(5):1175-1186. PubMed ID: 33939122
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies.
Dwivedi P; Kiran S; Han S; Dwivedi M; Khatik R; Fan R; Mangrio FA; Du K; Zhu Z; Yang C; Huang F; Ejaz A; Han R; Si T; Xu RX
ACS Appl Mater Interfaces; 2020 May; 12(21):23737-23751. PubMed ID: 32374147
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.
Tochizawa S; Masumori N; Yanai Y; Ohmoto Y; Yabuuchi Y; Tsukamoto T
Biomed Res; 2008 Dec; 29(6):271-8. PubMed ID: 19129670
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2.
Huang W; Xing Y; Zhu L; Zhuo J; Cai M
Exp Cell Res; 2021 Sep; 406(1):112633. PubMed ID: 34089726
[TBL] [Abstract][Full Text] [Related]
19. The natural medicinal fungus Huaier promotes the anti-hepatoma efficacy of sorafenib through the mammalian target of rapamycin-mediated autophagic cell death.
Zhang Z; Shen C; Zhou F
Med Oncol; 2022 Sep; 39(12):221. PubMed ID: 36175804
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-Triggered Delivery of Iproplatin from Microbubble-Conjugated Liposomes.
Browning R; Thomas N; Marsh LK; Tear LR; Owen J; Stride E; Farrer NJ
ChemistryOpen; 2021 Dec; 10(12):1170-1176. PubMed ID: 34708552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
